These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10365658)

  • 1. Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain/human multiple drug resistance 1 fusion gene.
    Dell'Acqua G; Polishchuck R; Fallon JT; Gordon JW
    Hum Gene Ther; 1999 May; 10(8):1269-79. PubMed ID: 10365658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of annamycin to adriamycin in cardiac and MDR tumor cell systems.
    Kolonias D; Podona T; Savaraj N; Gate L; Cossum P; Lampidis TJ
    Anticancer Res; 1999; 19(2A):1277-83. PubMed ID: 10368688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
    Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
    Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
    Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
    Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
    Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
    Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific and ligand-inducible target gene expression in transgenic mice.
    Bo J; Yu W; Zhang YM; Demayo FJ; Wei L
    J Mol Cell Cardiol; 2005 Apr; 38(4):685-91. PubMed ID: 15808845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes.
    Akimoto H; Bruno NA; Slate DL; Billingham ME; Torti SV; Torti FM
    Cancer Res; 1993 Oct; 53(19):4658-64. PubMed ID: 8402643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketotifen reverses MDR1-mediated multidrug resistance in human breast cancer cells in vitro and alleviates cardiotoxicity induced by doxorubicin in vivo.
    Zhang Y; Berger SA
    Cancer Chemother Pharmacol; 2003 May; 51(5):407-14. PubMed ID: 12687290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
    Li Y; Wang Y
    Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
    Park S; James CD
    Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
    Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
    Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
    Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA
    Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.